Skip to main content

Table 1 Characteristics of patients admitted for first-time myocardial infarction

From: Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population

Characteristic

Total n = 931

Prior CVD n = 166 (17.8 %)

No prior CVD n = 765 (82.2 %)

p

Age at admission to hospital, mean (SD)

70.6 (12.2)

78.3 (9.4)

68.9 (12.1)

<0.001

Female gender

345 (37.1 %)

71/166 (42.8 %)

274/765 (35.8 %)

0.093

Manual worker

531 (60.5 %)

96/151 (63.6 %)

435/727 (59.8 %)

0.392

Current smoker

198 (21.7 %)

21/159 (13.2 %)

177/755 (23.4 %)

0.004

Systolic blood pressure, mmHg, mean (SD) (67 missing)a

142 (18.4)

143 (18.7)

142 (18.3)

0.517

Diastolic blood pressure, mmHg, mean (SD) (67 missing)a

81 (11.2)

78 (12.5)

82 (10.7)

<0.001

Total cholesterol, mmol/L, mean (SD) (44 missing)

5.2 (2.2)

4.9 (1.3)

5.3 (2.4)

0.064

LDL cholesterol, mmol/L, mean (SD) (56 missing)

3.2 (1.1)

3.0 (1.1)

3.3 (1.1)

0.010

ST-elevation myocardial infarction

321 (34.5 %)

36/166 (21.7 %)

285/765 (37.3 %)

<0.001

Past medical history

    

 Revascularisation (CABG/PCI)

38 (4.1 %)

38/166 (22.9 %)

NA

-

 Ischaemic stroke or TIA

52 (5.6 %)

52/166 (31.3 %)

NA

-

Present conditions

    

 Angina pectoris, current diagnosis

109 (11.7 %)

109/166 (65.7 %)

NA

-

 Peripheral artery disease (PAD)

19 (2.0 %)

19/166 (11.4 %)

NA

-

 Hypertension, current diagnosis

511 (54.9 %)

124/166 (74.7 %)

387/765 (50.6 %)

<0.001

 Diabetes, current diagnosis

172 (18.5 %)

49/166 (29.5 %)

123/765 (16.1 %)

<0.001

Medication at admission to hospital

    

 ACE inhibitor/ARB

292 (31.5 %)

69/165 (41.8 %)

223/763 (29.2 %)

<0.002

 Beta-blockers

265 (28.6 %)

89/165 (53.9 %)

176/762 (23.1 %)

<0.001

 Calcium channel blockers

207 (22.4 %)

60/164 (36.6 %)

147/762 (19.3 %)

<0.001

 Diuretics

248 (26.8 %)

72/165 (43.6 %)

176/762 (23.1 %)

<0.001

 Long-acting nitroglycerine

49 (5.3 %)

45/165 (27.3 %)

4/763 (0.5 %)

<0.001

 Statins

161 (17.3 %)

57/165 (34.5 %)

104/763 (13.6 %)

<0.001

 Acetylsalicylic acid

222 (23.9 %)

112/165 (67.9 %)

110/763 (14.4 %)

<0.001

  1. ACE angiotensin-converting-enzyme inhibitor, ARB angiotensin-receptor blocker, CABG coronary artery bypass grafting, CVD cardiovascular disease, a composite of diagnoses including angina pectoris, prior revascularisation, ischaemic stroke/TIA, or PAD (leg artery disease, a stenosing lesion of the carotid or atherosclerotic aneurysm), Current diagnosis of diabetes is type 1 or type 2. LDL low density lipoprotein, PCI percutaneous coronary intervention, TIA transitory ischaemic attack, NA not applicable
  2. aLast representative blood pressure before admission to hospital